Trading Signals: MESO Stock Price Prediction and Forecast (Fri. Nov. 13, 2015 - Fri. May. 13, 2022)(Mesoblast Limited)
| MESO latest price $11.2400 (-5.11%) ($11.1650 - $11.5970) on Thu. Oct. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.86% (three month average) | RSI | 28 | Latest Price | $11.2400(-5.11%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | MESO declines -1.4% a day on average for past five trading days. | Weekly Trend | MESO declines -20.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support MESO advance at 0% a week (0% probability) DRIV(19%) EDOC(13%) CEMB(7%) EWY(7%) IGOV(5%) | Factors Impacting MESO price | MESO will decline at least -4.93% in a week (0% probabilities). SHY(-9%) VCSH(-7%) UNG(-5%) MCHI(-5%) KWEB(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.93% (StdDev 9.86%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-21.1(-287.72%) | Resistance Level | $14.91 | 5 Day Moving Average | $11.87(-5.31%) | 10 Day Moving Average | $12.04(-6.64%) | 20 Day Moving Average | $14.91(-24.61%) | To recent high | -43.2% | To recent low | 0% | Market Cap | $1.305b | | | | Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target the cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Itescu Silviu on June 8, 2004 and is headquartered in Melbourne, Australia. |